These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29266381)

  • 1. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
    Sailer V; Schiffman MH; Kossai M; Cyrta J; Beg S; Sullivan B; Pua BB; Lee KS; Talenfeld AD; Nanus DM; Tagawa ST; Robinson BD; Rao RA; Pauli C; Bareja R; Beltran LS; Sigaras A; Eng KW; Elemento O; Sboner A; Rubin MA; Beltran H; Mosquera JM
    Cancer; 2018 Mar; 124(5):1008-1015. PubMed ID: 29266381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy.
    Van Allen EM; Foye A; Wagle N; Kim W; Carter SL; McKenna A; Simko JP; Garraway LA; Febbo PG
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):23-7. PubMed ID: 24366412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
    Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
    Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients.
    Donners R; Fotiadis N; Figueiredo I; Blackledge M; Westaby D; Guo C; Fenor de la Maza MLD; Koh DM; Tunariu N
    Eur Radiol; 2022 Oct; 32(10):6820-6829. PubMed ID: 35881184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer.
    Donners R; Figueiredo I; Westaby D; Koh DM; Tunariu N; Carreira S; de Bono JS; Fotiadis N
    Cancer Imaging; 2023 Dec; 23(1):121. PubMed ID: 38102655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
    Bins S; Cirkel GA; Gadellaa-Van Hooijdonk CG; Weeber F; Numan IJ; Bruggink AH; van Diest PJ; Willems SM; Veldhuis WB; van den Heuvel MM; de Knegt RJ; Koudijs MJ; van Werkhoven E; Mathijssen RH; Cuppen E; Sleijfer S; Schellens JH; Voest EE; Langenberg MH; de Jonge MJ; Steeghs N; Lolkema MP
    Oncologist; 2017 Jan; 22(1):33-40. PubMed ID: 27662884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive prostate cancer with somatic loss of the homologous recombination repair gene FANCA: a case report.
    Hongo H; Kosaka T; Aimono E; Nishihara H; Oya M
    Diagn Pathol; 2020 Jan; 15(1):5. PubMed ID: 31931827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
    Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
    Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy.
    Robertson NL; Sala E; Benz M; Landa J; Scardino P; Scher HI; Hricak H; Vargas HA
    J Urol; 2017 Jul; 198(1):65-70. PubMed ID: 28216327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Assessment of Bone Metastasis in Prostate Cancer Using Synthetic Magnetic Resonance Imaging.
    Arita Y; Takahara T; Yoshida S; Kwee TC; Yajima S; Ishii C; Ishii R; Okuda S; Jinzaki M; Fujii Y
    Invest Radiol; 2019 Oct; 54(10):638-644. PubMed ID: 31192827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.
    Cornud F; Roumiguié M; Barry de Longchamps N; Ploussard G; Bruguière E; Portalez D; Malavaud B
    Radiology; 2018 May; 287(2):534-542. PubMed ID: 29361246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
    Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-Guided Bone Biopsies in Metastatic Castration-Resistant Prostate Cancer: Factors Predictive of Maximum Tumor Yield.
    Holmes MG; Foss E; Joseph G; Foye A; Beckett B; Motamedi D; Youngren J; Thomas GV; Huang J; Aggarwal R; Alumkal JJ; Beer TM; Small EJ; Link TM
    J Vasc Interv Radiol; 2017 Aug; 28(8):1073-1081.e1. PubMed ID: 28549709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
    Manson-Bahr D; Ball R; Gundem G; Sethia K; Mills R; Rochester M; Goody V; Anderson E; O'Meara S; Flather M; Keeling M; Yazbek-Hanna M; Hurst R; Curley H; Clark J; Brewer DS; McDermott U; Cooper C
    J Clin Pathol; 2015 Mar; 68(3):212-7. PubMed ID: 25586381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer diagnosed through the biopsy of the bone metastatic lesion; a case report].
    Ueda Y; Higuchii Y; Hashimoto T; Mitsui Y; Maruyamai T; Kondou N; Nojima M; Yamamoto S; Shincho M; Hirota S; Shima H
    Hinyokika Kiyo; 2007 May; 53(5):327-30. PubMed ID: 17561720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.
    Beer AJ; Schwarzenböck SM; Zantl N; Souvatzoglou M; Maurer T; Watzlowik P; Kessler H; Wester HJ; Schwaiger M; Krause BJ
    Oncotarget; 2016 May; 7(19):28151-9. PubMed ID: 27058620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
    Fei B; Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo O; Tade F; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Schuster DM
    J Urol; 2019 Aug; 202(2):413-421. PubMed ID: 30817240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.